Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2026
Hims & Hers rebrands Juniper into the Hers brand identity in Australia
As part of the Australian launch, Hims & Hers replaced the legacy Juniper entity—Eucalyptus's established women's health venture operated in Australia since 2021—with the Hers global brand identity, while retaining Australian-licensed physicians and continuity of local clinical oversight for existing subscribers.
2026
Hims & Hers launches women's health platform Hers in Australia
Hims & Hers Health has officially introduced its women-focused telehealth platform Hers to the Australian healthcare market, transforming the Juniper venture into the fully integrated Hers platform. The transitioned platform introduces expanded diagnostic and treatment categories including perimenopause and menopause support, advanced hair restoration formulations, and comprehensive weight management programs, following the company's $1.15 billion acquisition of Eucalyptus earlier in the year.
2026
Securities class action lawsuit filed against Hims & Hers Health
A securities class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026. The complaint alleges that defendants made materially false and/or misleading statements and failed to disclose material adverse facts, including that the company shared consumers' health information with third-party advertising platforms and charged consumers for prescriptions almost immediately after they submitted an intake form despite telling consumers they would be able to consult with a medical provider. Wolf Haldenstein Adler Freeman & Herz LLP announced the action, with the lead-plaintiff deadline set for November 2, 2026. The suit follows a July 29, 2026 enforcement action by the FTC, the People of the State of California and the Utah Division of Consumer Protection alleging deceptive prescription billing, difficult subscription cancellation and misleading privacy practices, after which Hims & Hers stock fell 14.73% to close at $25.00 per share.
2026
FTC sues Hims & Hers over privacy and billing practices
The U.S. Federal Trade Commission, joined by California and Utah, sued Hims & Hers in federal court, alleging that the company shared consumers’ sensitive health information with advertising platforms without consent and charged some customers for prescriptions or recurring subscriptions without adequate disclosure or approval. The allegations have not been determined by the court.
2020
Truework and Hims & Hers partner to provide COVID-19 testing access
Truework announced a partnership with Hims & Hers to give employees of Truework partner companies access to COVID-19 testing through the Hims & Hers platform.
2020
Hims and Hers launch group therapy services
Hims launched group therapy services through its Hims and Hers brands as part of an initial expansion into mental health services. The offerings include anonymized group therapy and guided meditation sessions.